tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Plus Therapeutics expands CNSide assay platform to State of California
PremiumThe FlyPlus Therapeutics expands CNSide assay platform to State of California
1M ago
Plus Therapeutics announces expansion of CNSide Team
Premium
The Fly
Plus Therapeutics announces expansion of CNSide Team
1M ago
Plus Therapeutics presents REYOBIQ data at WFNOS/SNO annual meeting
Premium
The Fly
Plus Therapeutics presents REYOBIQ data at WFNOS/SNO annual meeting
1M ago
Plus Therapeutics Gains Nasdaq Extension for Compliance
PremiumCompany AnnouncementsPlus Therapeutics Gains Nasdaq Extension for Compliance
2M ago
Plus receives additional extension to regain compliance with Nasdasq
Premium
The Fly
Plus receives additional extension to regain compliance with Nasdasq
2M ago
Plus Therapeutics highlights ReSPECT-LM trial results at SITC meeting
Premium
The Fly
Plus Therapeutics highlights ReSPECT-LM trial results at SITC meeting
2M ago
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test
Premium
Ratings
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test
4M ago
Buy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments
Premium
Ratings
Buy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100